California's cattle producers and agricultural communities are all too familiar with the rising challenge of antibiotic resistance, making common bacterial infections harder to treat in livestock. But imagine a future where we could tackle these infections with a natural, powerful alternative. Our research points to just that: antimicrobial peptides (AMPs) found in African catfish.
We're really excited about these peptides because African catfish thrive in pathogen-rich freshwater, naturally producing these robust immune compounds in their skin mucus as a defense. This natural origin makes them highly appealing alternatives to synthetic drugs.
Predicted Safety and Potent Action
One of the most compelling aspects of these AMPs is their predicted safety for mammals. Our initial computer analyses suggest that various catfish AMPs are generally recognized as safe (GRAS). We predict they'll be absorbed in the human intestine without causing liver, brain, or heart toxicity. Furthermore, lab tests on a promising peptide, NACAP-II, confirmed it was non-hemolytic, meaning it didn't damage rabbit red blood cells—a strong indicator of its potential safety for mammalian cells.
Beyond safety, these peptides demonstrate effectiveness against problematic bacteria. One study revealed NACAP-II's strong activity against Extended-Spectrum Beta-Lactamase (ESBL)-producing Escherichia coli—a critical concern for both animal and human health due to its resistance to many common antibiotics. Another peptide, ACAP-IV, also showed antibacterial activity against E. coli and Staphylococcus aureus. We believe these AMPs work by directly disrupting bacterial cell membranes, a mechanism that makes it harder for bacteria to develop resistance compared to how they resist traditional antibiotics.
Sac Valley Prune News - Bloom 2026
